KRT17 Accelerates Cell Proliferative and Invasive Potential of Laryngeal Squamous Cell Carcinoma (LSCC) through Regulating AKT/mTOR and Wnt/β-Catenin Pathways

Table 2

Correlation between KRT17 and clinicopathological features of LSCC patients (n = 42).

Characteristic	No. (n = 42)	KRT17 expression level		value
		Low (n = 23)	High (n = 19)
Gender				0.845
Female	17	9	8
Male	25	14	11
Primary location				0.248
Supraglottic	27	13	14
Glottic	15	10	5
T classification				0.001
T1 + T2	20	17	3
T3 + T4	22	6	16
Differentiation				0.002
High	20	6	14
Moderate + poor	22	17	5
Lymph node metastasis				0.016
Yes	18	6	12
No	24	17	7
Clinical stage				0.03
I + II	21	15	6
III + IV	21	8	13

A significant difference compared with the KRT17 low expression group. , , and .